NANO MOBILE HEALTHCARE, INC. (OTCMKTS:VNTH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers

On May 23, 2017, Steven Steinhubl resigned from the board of
directors of the Company and such resignation was not the result
of any disagreement related to the operations, policies or
practices of the Company.

On May 23, 2017, Tony van Bijleveld resigned from the board of
directors of the Company and such resignation was not the result
of any disagreement related to the operations, policies or
practices of the Company.

On May 30, 2017, Robert Chicoski was appointed to serve as the
Companys Chief Financial Officer and as a member of the Companys
board of directors.

Robert Chicoski. Since 2004 Mr. Chicoski has
been the acting CFO for two Boston-based businesses providing
contract CFO services for all accounting, finance, tax and bank
financing matters as well as other strategic business and
corporate matters. From June 2012 through April 2017, Mr.
Chicoski was the controller, acting Chief Financial Officer and
Private Investor Mentor for GVP Global Corp, a Boston private
equity investment company. Mr. Chicoski has been a Certified
Public accountant since 1969. He was the founder, Treasurer and
Chief Financial Officer of a start- up company,World Energy
Solutions, that was previously listed on the Over the Counter
Exchange as XWES and subsequently acquired by EnerNOC in 2015.
Mr. Chicoski received a BS in Accounting from Bentley College of
Accounting and Finance.

On May 30, 2017, James C. Katzaroff was appointed to serve as a
member of the Companys board of directors.

James C. Katzaroff. Mr.Katzaroff is the founder
of Advanced Medical Isotope Corp. (Symbol: ADMD) and was the
Chief Executive Officer from 2007 through December 2016. Mr.
Katzaroff continues to serve as a director of ADMD. ADMDis a late
stage radiation oncology focused medical device company engaged
in the development of yttrium-90 based brachytherapy devices for
the treatment of non-resectable tumors. Mr. Katzaroff holds a
BachelorsDegreeinBusinessEconomicsfromtheUniversityofCalifornia,Santa
Barbara andhascompletedadvancedmanagementcoursesat
theUniversityofWashington.

Item 9.01. Financial Statements and Exhibits.

None

This Current Report on Form 8-K may contain, among other things,
certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, including,
without limitation, (i) statements with respect to the Companys
plans, objectives, expectations and intentions; and (ii) other
statements identified by words such as may, could, would, should,
believes, expects, anticipates, estimates, intends, plans or
similar expressions. These statements are based upon the current
beliefs and expectations of the Companys management and are
subject to significant risks and uncertainties. Actual results
may differ from those set forth in the forward-looking
statements. These forward-looking statements involve certain
risks and uncertainties that are subject to change based on
various factors (many of which are beyond the Companys control).
The Company does not undertake a duty to update any forward
looking statements made in this Form 8-K.

About NANO MOBILE HEALTHCARE, INC. (OTCMKTS:VNTH)

Nano Mobile Healthcare, Inc. is a mobile health technology company. The Company is developing personalized and point-of-care screening using applications based upon chemical sensing methods. Its screening device will detect and analyze common components from human breath and provide an early indication of chronic diseases, such as heart failure and various forms of cancer, as well as contagious diseases, such as strep throat. Its product, Nano Mobile Sensor, screens for various combinations so the doctor can identify them before symptoms appear, such as a tumor that appears when patients have a computed tomography scan. The sensor connects through Bluetooth to any smart device running an iPhone operating system or Android operating system. The screening device includes Breath Capture Device, Sensor Module and Application/Software for the Smart Devices. The Nano Mobile Sensor detects chemicals and volatile organic compounds using Carbon Nanotubes.

NANO MOBILE HEALTHCARE, INC. (OTCMKTS:VNTH) Recent Trading Information

NANO MOBILE HEALTHCARE, INC. (OTCMKTS:VNTH) closed its last trading session 00.00000 at 0.00070 with shares trading hands.